Here are 5 interesting findings from the September 2019 issue of AJMC®.
Hi, I’m Christina Mattina for The American Journal of Managed Care®. Here are 5 findings from research published in the September issue.
Did Medicare Advantage Payment Cuts Affect Beneficiary Access and Affordability?
1. Payment cuts to Medicare Advantage under the Affordable Care Act did not appear to make the program less attractive to plans or enrollees. Not only did enrollment in MA grow between 2009 and 2017, but access and affordability remained stable for beneficiaries.
VA Geriatric Scholars Program’s Impact on Prescribing Potentially Inappropriate Medications
2. Participation in the Veterans Affairs Geriatric Scholars Program course, which teaches providers about best practices on appropriate prescribing, was associated with reduced prescribing of potentially dangerous or inappropriate medications for older veterans in VA primary care.
Changes in Ambulatory Utilization After Switching From Medicaid Fee-for-Service to Managed Care
3. After some New York Medicaid beneficiaries switched from fee-for-service to managed care, those who switched had larger decreases in ambulatory visits and providers than those who were continuously enrolled in either fee-for-service or managed care. The patterns were mainly driven by changes among beneficiaries with 5 or more chronic conditions.
4. Compared with Medicare fee-for-service beneficiaries, nursing home residents in MA Institutional Special Needs Plans had different patterns of healthcare use across various settings, including lower emergency department use and hospital admissions and readmissions, but higher use of skilled nursing facilities.
Multi-Payer Advanced Primary Care Practice Demonstration on Quality of Care
5. The Multi-Payer Advanced Primary Care Practice Demonstration was intended to improve care by facilitating the transformation to a patient-centered medical home, but a study of claims and enrollment data found few significant improvements in quality after the demonstration period across 8 participating states.
To read all of these studies and more, visit AJMC.com.
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More